Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Walkty
John Embil

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
The Journal of Antimicrobial Chemotherapy|September 11, 2019
Trends in antimicrobial resistance over 10 years among key bacterial pathogens from Canadian hospitals: results of the CANWARD study 2007-16Philippe R S Lagacé-Wiens, Heather J Adam, Susan Poutanen, et al.
Drugs|February 13, 2015
Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogensGeorge G Zhanel, Riley Love, Heather Adam, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2008
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006George G Zhanel, Mel DeCorby, Nancy Laing, et al.
Drugs|November 28, 2020
Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial PneumoniaGeorge G Zhanel, Christina Deng, Sheryl Zelenitsky, et al.
The Journal of Antimicrobial Chemotherapy|August 28, 2025
Gram-positive pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007-23)George G Zhanel, Melanie R Baxter, Alyssa R Golden, et al.
Drugs|March 16, 2022
Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant BacteriaGeorge G Zhanel, Marianna Pozdirca, Alyssa R Golden, et al.
The Journal of Antimicrobial Chemotherapy|August 28, 2025
Gram-negative pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007-23)George G Zhanel, Melanie R Baxter, Philippe Lagacé-Wiens, et al.
Expert Review of Anti-Infective Therapy|July 15, 2024
How is ceftobiprole used in Canada: the CLEAR study final resultsGeorge G Zhanel, Justin Kosar, Melanie Baxter, et al.
The Journal of Antimicrobial Chemotherapy|September 11, 2019
42936 pathogens from Canadian hospitals: 10 years of results (2007-16) from the CANWARD surveillance studyGeorge G Zhanel, Heather J Adam, Melanie R Baxter, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|March 11, 2021
Correction to: Intravenous immune globulin in septic shock: a Canadian national survey of critical care medicine and infectious disease specialist physiciansMurdoch Leeies, Hayley B Gershengorn, Emmanuel Charbonney, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
The Journal of Antimicrobial Chemotherapy|September 11, 2019
Trends in antimicrobial resistance over 10 years among key bacterial pathogens from Canadian hospitals: results of the CANWARD study 2007-16Philippe R S Lagacé-Wiens, Heather J Adam, Susan Poutanen, et al.
Drugs|February 13, 2015
Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogensGeorge G Zhanel, Riley Love, Heather Adam, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2008
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006George G Zhanel, Mel DeCorby, Nancy Laing, et al.
Drugs|November 28, 2020
Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial PneumoniaGeorge G Zhanel, Christina Deng, Sheryl Zelenitsky, et al.
The Journal of Antimicrobial Chemotherapy|August 28, 2025
Gram-positive pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007-23)George G Zhanel, Melanie R Baxter, Alyssa R Golden, et al.
Drugs|March 16, 2022
Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant BacteriaGeorge G Zhanel, Marianna Pozdirca, Alyssa R Golden, et al.
The Journal of Antimicrobial Chemotherapy|August 28, 2025
Gram-negative pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007-23)George G Zhanel, Melanie R Baxter, Philippe Lagacé-Wiens, et al.
Expert Review of Anti-Infective Therapy|July 15, 2024
How is ceftobiprole used in Canada: the CLEAR study final resultsGeorge G Zhanel, Justin Kosar, Melanie Baxter, et al.
The Journal of Antimicrobial Chemotherapy|September 11, 2019
42936 pathogens from Canadian hospitals: 10 years of results (2007-16) from the CANWARD surveillance studyGeorge G Zhanel, Heather J Adam, Melanie R Baxter, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|March 11, 2021
Correction to: Intravenous immune globulin in septic shock: a Canadian national survey of critical care medicine and infectious disease specialist physiciansMurdoch Leeies, Hayley B Gershengorn, Emmanuel Charbonney, et al.
Pageof 14